Schizophrenia
Showing NaN - NaN of 188
Schizophrenia Trial in San Diego, Richardson (CVL-231 10 mg, Required CVL-231 30 mg, Placebo)
Recruiting
- Schizophrenia
- CVL-231 10 mg
- +2 more
-
Little Rock, Arkansas
- +15 more
Jan 27, 2023
Schizophrenia Trial in Bentonville, Sherman Oaks, Chicago (CVL-231 15 mg, Required CVL-231 30 mg, Placebo)
Recruiting
- Schizophrenia
- CVL-231 15 mg
- +2 more
-
Bentonville, Arkansas
- +12 more
Jan 27, 2023
Schizophrenia Trial in Worldwide (SEP-363856 50mg, SEP-363856 75mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 50mg
- +2 more
-
Little Rock, Arkansas
- +58 more
Dec 12, 2022
Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 75mg
- +2 more
-
Little Rock, Arkansas
- +63 more
Dec 12, 2022
Schizophrenia Trial (CVL-231 30 mg)
Enrolling by invitation
- Schizophrenia
- CVL-231 30 mg
-
Bentonville, Arkansas
- +16 more
Dec 7, 2022
Schizophrenia Trial in United States (SEP-363856, Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole))
Recruiting
- Schizophrenia
- SEP-363856
- Prior antipsychotic (risperidone, olanzapine, quetiapine or aripiprazole)
-
Little Rock, Arkansas
- +6 more
Nov 11, 2022
Schizophrenia Trial in Worldwide (BI 425809, Placebo)
Completed
- Schizophrenia
- BI 425809
- Placebo
-
Little Rock, Arkansas
- +50 more
Nov 7, 2022
Schizophrenia Trial in San Diego (Memantine, Placebo)
Completed
- Schizophrenia
- Memantine
- Placebo
-
San Diego, CaliforniaUniversity of California, San Diego
Sep 30, 2022
Schizophrenia Trial in United States (Xanomeline and Trospium Chloride Capsules, Placebo)
Recruiting
- Schizophrenia
- Xanomeline and Trospium Chloride Capsules
- Placebo
-
Little Rock, Arkansas
- +18 more
Aug 12, 2022
Schizophrenia, Schizophrenia; Psychosis Trial in Ukraine, United States (Xanomeline and Trospium Chloride Capsules, Placebo)
Recruiting
- Schizophrenia
- Schizophrenia; Psychosis
- Xanomeline and Trospium Chloride Capsules
- Placebo
-
Bentonville, Arkansas
- +28 more
Aug 12, 2022
Schizophrenia, Schizoaffective Disorder Trial in San Diego (Memantine, Placebo)
Recruiting
- Schizophrenia
- Schizoaffective Disorder
- Memantine
- Placebo
-
San Diego, CaliforniaClinical Teaching Facility (CTF B-403 at UCSD Medical Center)
Aug 8, 2022
Schizophrenia Trial in Worldwide (BI 425809)
Recruiting
- Schizophrenia
- BI 425809
-
Anaheim, California
- +37 more
Aug 8, 2022
Schizophrenia, Bipolar I Disorder, Autism Spectrum Disorder (ASD) Trial in Puerto Rico, United States (Cariprazine Flexible
Recruiting
- Schizophrenia
- +2 more
- Cariprazine Flexible Dose
-
Dothan, Alabama
- +32 more
Aug 8, 2022
Schizophrenia Trial in Ukraine, United States (Risperidone ISM 75 mg, Risperidone ISM 100 mg)
Completed
- Schizophrenia
- Risperidone ISM 75 mg
- Risperidone ISM 100 mg
-
Rogers, Arkansas
- +23 more
Feb 24, 2022
Schizophrenia Trial in Worldwide (SEP363856, quetiapine XR)
Active, not recruiting
- Schizophrenia
- SEP363856
- quetiapine XR
-
Cerritos, California
- +45 more
Feb 16, 2022
Schizophrenia, Schizophreniform Disorder, Bipolar I Disorder Trial in Worldwide (ALKS 3831)
Active, not recruiting
- Schizophrenia
- +2 more
- ALKS 3831
-
Little Rock, Arkansas
- +85 more
Feb 10, 2022